| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |